RIDGEFIELD, Conn., Dec. 1 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the Mind, Body, HAART Web site (www.MindBodyHAART.com), a single-destination resource for people living with HIV, people affected by HIV and those caring for people with HIV. The site provides tools and helpful tips on how to maintain mental, physical and emotional well-being when dealing with the daily challenges of the disease.
To view the Multimedia News Release, go to: http://multivu.prnewswire.com/mnr/boehringeringelheim/41348/
“MindBodyHAART.com is a resource for the HIV community at large, which recognizes the need for a team approach to successful HIV management,” says Valerie Wojciechowicz, an HIV patient educator living with HIV for over 20 years. “BI has created an informational resource to inform and support the entire HIV community -- from patients and their families, to caregivers and educators -- and help anyone affected by the disease to identify ways for dealing with it more effectively.”
MindBodyHAART.com can help patients, families and caregivers:
MindBodyHAART.com can help physicians & HIV/AIDS educators:
The features of MindBodyHAART.com for patients, families, caregivers, physicians and HIV/AIDS educators include:
About MindBodyHAART.com
For nearly 125 years, Boehringer Ingelheim has focused on discovering innovative ways -- through both science and disease education -- to improve the quality of life for patients and their families. MindBodyHAART.com is a primary example of this dedication as the Web site was created to provide useful advice, facts and information for patients, caregivers, physicians and community educators. The goal of the site is to help enhance HIV/AIDS care and treatment by fostering an open dialogue. The site’s namesake encompasses the mental and emotional (MIND), physical (BODY) and treatment (HAART) challenges that come with living with HIV.
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximately 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.
For more information, please visit http://us.boehringer-ingelheim.com
CONTACT: Susan Holz, Public Affairs & Communications of Boehringer
Ingelheim Pharmaceuticals, Inc., +1-203-798-4265,
usnews@boehringer-ingelheim.com
Web site: http://www.MindBodyHAART.com/
http://us.boehringer-ingelheim.com/
